,,ii #aahth ,,congress #b;d ,session ,s4 #ebgh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,september #be1 #bjbd,mr4 ,booker introduced the following bill2 which was read twice and referred to the ,committee on ,foreign ,relations ,a ,,bill ,to provide additional authorities for the leadership of the ,united ,states ,agency for ,international ,development in health technology innovation for global health in low-resource settings1 and for other purposes4 #a4 ,short titles2 table of contents 7a7 ,short titles ,this ,act may be cited as the ,supporting ,innovative ,global ,health ,technologies ,act of #bjbd or the ,,sight ,act4 7b7 ,table of contents ,the table of contents for this ,act is as follows3 ,sec4 #a4 ,short titles2 table of contents4,sec4 #b4 ,findings4,sec4 #c4 ,statement of policy4,sec4 #d4 ,definitions4,sec4 #e4 ,chief ,innovation ,officer for ,health4,sec4 #f4 ,global ,health ,research and ,development ,advisory ,council4,sec4 #g4 ,global ,health ,research and ,development program area activities and budget4,sec4 #h4 ,grant program for expanded use of global health research and development4,sec4 #i4 ,strategy and reports4 #b4 ,findings ,congress finds the following3 7#a7 ,the ,united ,states ,agency for ,international ,development has-- 7,a7 a unique role in the research and development of health technologies for global health that complements the work of other departments and agencies of the ,united ,states ,government2 and 7,b7 both an advantage and a unique mandate for the development of health technologies to be used in low-resource settings4 7#b7 ,it is in the national interest of the ,united ,states to build greater country capacity for research and development of new health technologies to be used in low- and middle-income countries4 7#c7 ,investments by the ,united ,states ,government in global health research and development should be coordinated with1 and leverage investments from1 partner country governments1 other government donors1 and the private sector4 7#d7 ,human immunodeficiency virus 7,,hiv71 tuberculosis 7,,tb71 malaria1 neglected tropical diseases1 emerging infectious diseases 7such as ,,covid-#ai1 ,ebola1 and ,zika71 and many other health conditions 7such as complications in pregnancy7 have a disproportionate public health burden in low- and middle-income countries4 7#e7 ,health technologies that were developed for use in high-income countries often cannot be implemented in low-resource settings in low- and middle-income countries or require adaptation to be effective4 7#f7 ,due to poverty or low incidence1 many neglected tropical diseases and emerging infectious diseases either lack or have limited commercial markets to drive health technology innovation4 7#g7 ,achieving the ambitious goals set through initiatives such as the ,president's ,emergency ,plan for ,,aids ,relief 7commonly referred to as ,,pepfar7 and the ,president's ,malaria ,initiative 7commonly referred to as ,,pmi7 will not be possible without the development and scale-up of new health technologies designed for use in low-resource settings1 which are needed to address both long-standing endemic diseases and prepare for potential pandemic threats4 7#h7 ,public funding has proven highly successful at incentivizing the development of health technologies for global health that are high-impact1 accessible1 and cost-saving4 7#i7 ,,covid-#ai has demonstrated the importance of global access to health technologies designed for low-resource settings4 7#aj7 ,support for the development of accessible health technologies for low-resource settings can have reciprocal value and produce tools that reduce health care costs1 improve public health1 and strengthen health security for the ,united ,states4 7#aa7 ,for decades1 ,,usaid has been a catalyst in the global health innovation ecosystem4 ,while other ,federal departments and agencies1 including the ,national ,institutes of ,health1 the ,centers for ,disease ,control and ,prevention1 and the ,department of ,defense1 provide support for global health technologies1 ,,usaid is the only ,federal agency that provides broad support for the late-stage development of new health technologies to combat neglected tropical diseases1 emerging infectious diseases1 and other health conditions for low-resource settings4 7#ab7 ,while the need for new tools to tackle disease threats has grown in recent years1 investments by ,,usaid in research and development have shrunk as a proportion of its overall global health spending and have been squeezed by stagnant budgets and growing needs4 7#ac7 ,innovation at ,,usaid is primarily supported from siloed disease- and population-specific appropriations accounts1 resulting in the limitation of its ability to seek shared value across health sectors or health threats4 7#ad7 ,,usaid is compelled to prioritize support for immediate program needs with imperfect tools at the expense of support for technologies that can improve clinical effectiveness1 increase access to care1 save costs1 and build capacity and ownership by partner countries4 #c4 ,statement of policy ,it is the policy of the ,united ,states that-- 7#a7 research and development for new health technologies-- 7,a7 is essential for the success of the global health programs of the ,united ,states ,government2 and 7,b7 provides for the improved effectiveness1 cost-effectiveness1 and sustainability of such programs2 and 7#b7 funding and other support for global health research and development under this ,act shall be additional and complementary to1 and may not replace1 displace1 or otherwise compromise1 funding otherwise provided for-- 7,a7 existing and ongoing global health research and development of the ,united ,states ,government2 or 7,b7 activities relating to the implementation of the global health programs of the ,united ,states ,government4 #d4 ,definitions ,in this ,act3 7#a7 ,administrator ,the term ,administrator means the ,administrator of the ,united ,states ,agency for ,international ,development4 7#b7 ,appropriate congressional committees ,the term appropriate congressional committees means-- 7,a7 the ,committee on ,foreign ,relations of the ,senate2 and 7,b7 the ,committee on ,foreign ,affairs of the ,house of ,representatives4 7#c7 ,global health ,the term global health includes efforts to combat and prepare for-- 7,a7 neglected tropical diseases2 7,b7 emerging infectious diseases2 7,c7 antimicrobial resistance2 and 7,d7 any other condition that may not be easily treated1 diagnosed1 or prevented in low-resource settings4 7#d7 ,global health research and development ,the term global health research and development includes an activity1 or the support for such an activity1 related to research1 development1 testing1 evaluation1 deployment1 or implementation of any new health technology4 7#e7 ,health technology ,the term health technology-- 7,a7 means a vaccine1 therapeutic1 diagnostic1 device1 or other tool designed1 modified1 or adapted for use in low-resource settings to improve global health2 and 7,b7 includes personal protective equipment and insecticide so used4 7#f7 ,low-resource setting ,the term low-resource setting means a location with limited or inconsistent access to running water1 electricity1 refrigeration1 supply chains1 lab services1 medical equipment1 trained health care personnel1 or other resources important for global health4 7#g7 ,,usaid ,the term ,,usaid means the ,united ,states ,agency for ,international ,development4 #e4 ,chief ,innovation ,officer for ,health 7a7 ,establishment ,there is established1 within the ,,usaid ,bureau for ,global ,health1 the position of ,chief ,innovation ,officer for ,health1 which shall be classified at the level of ,deputy ,assistant ,administrator or equivalent4 7b7 ,appointment ,the ,administrator shall appoint the ,chief ,innovation ,officer for ,health from among such individuals as the ,administrator determines have-- 7#a7 relevant experience within private sector industry2 and 7#b7 an expert understanding of health finance and the research1 development1 testing1 evaluation1 deployment1 and implementation of new health technology4 7c7 ,relationship to ,assistant ,administrator for ,global ,health ,the ,chief ,innovation ,officer for ,health shall-- 7#a7 serve as the principal advisor to the ,,usaid ,assistant ,administrator for ,global ,health regarding global health research and development necessary to meet the requirements of the ,united ,states ,government and the governments of partner countries for improving global health2 and 7#b7 report directly to the ,,usaid ,assistant ,administrator for ,global ,health4 7d7 ,duties ,the ,chief ,innovation ,officer for ,health shall-- 7#a7 ensure cross-sector1 ,,usaid-wide cooperation1 support1 and programming for global health research and development-- 7,a7 to increase the effectiveness of ,,usaid international development programs2 and 7,b7 to support the foreign policy and development goals of the ,united ,states ,government2 7#b7 draw on the expertise of other ,federal departments and agencies and of nongovernmental organizations 7including affected communities and institutions in low- or middle-income countries1 businesses1 health and science research organizations1 and institutions of higher education7 that pursue global health-related research and development to identify the most pressing requirements for the development of health technologies that will improve global health and ,,usaid programs relating to global health2 7#c7 leverage research and investments by other ,,usaid components1 other ,federal departments and agencies1 and nongovernmental organizations 7including businesses1 health and science research organizations1 institutions of higher education1 and governments or other institutions of partner countries7 to support the research and development of new health technologies by the ,chief ,innovation ,officer for ,health2 7#d7 administer the processes for awarding grants1 entering into partnerships1 and jointly establishing other arrangements to support global health research and development 7including by administering the grant program required under section #h72 and 7#e7 serve as the ,chairperson of the ,global ,health ,research and ,development ,advisory ,council established pursuant to section #f4 7e7 ,authorities ,the ,,usaid ,assistant ,administrator for ,global ,health shall take such steps as may be necessary to ensure that the ,chief ,innovation ,officer for ,health has sufficient authority within the ,bureau for ,global ,health to carry out the duties described in subsection 7d74 #f4 ,global ,health ,research and ,development ,advisory ,council 7a7 ,establishment ,the ,administrator shall establish an advisory council1 which shall be known as the ,global ,health ,research and ,development ,advisory ,council 7referred to in this section as the ,council74 7b7 ,membership ,the ,council shall be composed of-- 7#a7 the ,,usaid ,chief ,innovation ,officer for ,health1 who shall serve as the ,chair of the ,council 7referred to in this section as the ,chair72 7#b7 not more than #h additional members1 who shall be appointed by the ,administrator from among individuals who-- 7,a7 have been recommended for such appointment by the ,chair2 and 7,b7 are scientists or other experts with experience in global health research and development through or on behalf of-- 7i7 ,,usaid2 7ii7 any other ,federal department or agency2 7iii7 affected communities in low- or middle-income countries2 or 7iv7 nongovernmental organizations1 including nonprofit organizations1 businesses1 and institutes of higher education4 7c7 ,terms 7#a7 ,in general ,each member of the ,council other than the ,chair shall be appointed for a #f-year term4 7#b7 ,vacancies ,any member appointed to fill a vacancy occurring before the expiration of the term for which the predecessor of the member was appointed shall be appointed only for the remainder of such term4 ,a vacancy in the ,council shall be filled in the manner in which the original appointment was made4 7d7 ,compensation 7#a7 ,prohibition of compensation of ,federal employees ,except as provided in paragraph 7#b71 members of the ,council who are full-time officers or employees of the ,united ,states may not receive additional pay1 allowances1 or benefits by reason of their service on the ,council4 7#b7 ,travel expenses ,each member of the ,council shall receive travel expenses1 including per diem in lieu of subsistence1 in accordance with applicable provisions under subchapter ,i of chapter #eg of title #e1 ,united ,states ,code4 7e7 ,meetings ,the ,council shall meet at the call of the ,chair4 7f7 ,duties ,the ,council shall be responsible for advising the ,administrator regarding ,,usaid priorities and objectives with respect to global health research and development1 including by providing such advice on an individual member basis or as a collective ,council1 as the ,chair may direct4 7g7 ,nonapplicability of ,federal ,advisory ,committee ,act ,chapter #aj of title #e1 ,united ,states ,code 7commonly referred to as the ,federal ,advisory ,committee ,act71 shall not apply to the ,council4 #g4 ,global ,health ,research and ,development program area activities and budget 7a7 ,in general ,the ,administrator shall carry out global health research and development activities with respect to new health technologies with the potential to advance the effectiveness and sustainability of ,,usaid global health programs1 including the potential to advance-- 7#a7 health technologies with characteristics identified or otherwise prioritized by affected communities and partner countries2 7#b7 health technologies with characteristics that facilitate introduction and access of the respective technology to ensure use by those in need2 and 7#c7 support for capacity-building within partner countries and the transition by such countries to greater country-level ownership1 responsibility1 and decision-making with respect to global health4 7b7 ,budget ,not later than #ij days after the date of the enactment of this ,act1 the ,administrator shall-- 7#a7 establish a single1 separate budget line for the activities described in subsection 7a71 under which funds made available to the ,administrator to carry out such activities shall be categorized2 and 7#b7 include information regarding amounts expended and requested to be expended under such budget line in the budget justification materials submitted in support of the budget of the ,president for each fiscal year beginning on or after the date on which such budget line is established4 #h4 ,grant program for expanded use of global health research and development 7a7 ,grant program ,the ,administrator1 acting through the ,chief ,innovation ,officer for ,health appointed pursuant to section #e1 shall carry out a grant program under which the ,administrator may award competitive grants to nongovernmental organizations that the ,administrator determines to be eligible4 7b7 ,use of amounts ,grant amounts awarded pursuant to this section may only be used-- 7#a7 to develop new health technologies designed for use in low-resource settings to improve global health2 7#b7 to evaluate and improve the implementation1 production1 and scale-up of health technologies in low-resource settings in partner countries2 and 7#c7 to invest in the research capacity of institutions in low- and middle-income partner countries to lead and contribute to the development of health technologies4 7c7 ,conditions on grant award ,the ,administrator may not award a grant to an entity under this section unless-- 7#a7 such entity submits to the ,administrator a proposal demonstrating sufficient technical standards1 as determined by the ,administrator1 for any of the purposes listed in paragraphs 7#a7 through 7#c7 of subsection 7b7 for which the entity intends to use such grant amounts2 7#b7 the entity agrees1 as a condition of receiving such grant1 to report not less frequently than annually to the ,administrator regarding the use of such grant amounts during the grant period2 and 7#c7 the ,administrator certifies to the appropriate congressional committees that such award is in compliance with section #c7b74 7d7 ,additional nature of authority ,the authority to award grants under this section is in addition to1 and not in lieu of1 any other authority of the ,administrator1 including any such authority under part ,i or ,,ii of the ,foreign ,assistance ,act of #aifa 7#bb ,u4,s4,c4 #baea et seq474 #i4 ,strategy and reports 7a7 ,report on progress ,not later than #ahj days after the date of the enactment of this ,act1 and before submitting the budget justification materials in support of the budget of the ,president for the first fiscal year beginning after the date of the enactment of this ,act1 the ,administrator shall submit to the appropriate congressional committees1 and publish on a publicly available ,,usaid website1 a report containing-- 7#a7 a detailed description of the status of the ,global ,health ,research and ,development ,advisory ,council established pursuant to section #f2 7#b7 recommendations by the ,global ,health ,research and ,development ,advisory ,council2 7#c7 solicitations for grant awards authorized under section #h2 7#d7 a comprehensive accounting of awards and objectives to be included within the annual report to ,congress on the ,,usaid health-related research and development strategy required under the ,department of ,state1 ,foreign ,operations1 and ,related ,programs ,appropriations ,act for the relevant fiscal year 7or by a report accompanying such ,act from the ,committee on ,appropriations of the ,senate or the ,committee on ,appropriations of the ,house of ,representatives72 7#e7 a detailed description of how planned investments by ,,usaid in the activities described in section #g7;a7 align with ,,usaid's multiyear strategy titled ,global ,health ,research and ,development ,strategy #bjbc-bjbh and developed pursuant to section #gjai7;e7 of division ,k of the ,consolidated ,appropriations ,act1 #bjbb 7,public ,law #aag-ajc72 and 7#f7 a detailed description of how investments made by ,,usaid in such activities advance the other ,,usaid health-related programming goals4 7b7 ,annual reports ,not later than #a year after the date of the enactment of this ,act1 and annually thereafter for the following #e years as part of the annual report referred to in subsection 7a77#d71 the ,administrator shall submit to the appropriate congressional committees1 and publish on a publicly available ,,usaid website1 a report containing1 with respect to the fiscal year covered by the report-- 7#a7 information on any grants awarded1 or other assistance provided1 by the ,administrator during such year pursuant to this ,act or any other relevant provision of law for the support of global health research and development in support of ,,usaid programs2 7#b7 the primary1 secondary1 and tertiary purposes of-- 7,a7 any such grants awarded2 and 7,b7 any investments in the activities described in section #g7;a7 made or proposed by the ,administrator during such year2 7#c7 a summary of the consultations with communities and researchers based in partner countries regarding any such investments2 7#d7 a description of the outcomes and status of the activities described in section #g7;a7 that were carried out or otherwise supported by the ,administrator during such fiscal year2 7#e7 the identification of any amounts obligated or expended during such year by the ,administrator from any appropriations account to support global health research and development1 presented both as a summary and in a table that is disaggregated by health area1 type of research or development activity1 and appropriations account2 and 7#f7 a description of relevant objectives and expected outcomes for the subsequent fiscal year4